➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Baxter
Merck
Mallinckrodt
Harvard Business School

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Details for Patent: 6,548,079


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,548,079
Title: Moxifloxacin formulation containing common salt
Abstract:The present invention relates to an aqueous formulation comprising moxifloxacin hydrochloride and sodium chloride, to the formulation for use as a medicament and to the use of the formulation for preparing a medicament for preventing or treating bacterial infections in humans or animals.
Inventor(s): Kuhn; Bernd (Koln, DE), Mahler; Hans-Friedrich (Koln, DE), Eisele; Michael (Bergisch Gladbach, DE)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:10/049,095
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use; Composition;

Drugs Protected by US Patent 6,548,079

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,548,079

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany199 37 116Aug 06, 1999
PCT Information
PCT FiledJuly 25, 2000PCT Application Number:PCT/EP00/07098
PCT Publication Date:February 15, 2001PCT Publication Number: WO01/10465

International Family Members for US Patent 6,548,079

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 025001 ⤷  Free Forever Trial
Austria 270104 ⤷  Free Forever Trial
Australia 6159600 ⤷  Free Forever Trial
Australia 771058 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Boehringer Ingelheim
AstraZeneca
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.